Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2020.02.28
第四届董事会第三十次会议决议公告
2020.02.26
2020年面向合格投资者公开发行公司债券（疫情防控债）票面利率公告
2020.02.26
2020年面向合格投资者公开发行公司债券（疫情防控债）发行相关情况的调整公告
2020.02.26
2020年面向合格投资者公开发行公司债券（疫情防控债）发行相关情况的调整公告
2020.02.25
2020年公开发行公司债券信用评级报告
2020.02.25
2020年面向合格投资者公开发行公司债券（疫情防控债）更名公告
2020.02.25
2020年公开发行公司债券（疫情防控债）募集说明书（面向合格投资者）
2020.02.25
2020年公开发行公司债券（疫情防控债）募集说明书摘要（面向合格投资者）
2020.02.25
2020年公开发行公司债券（疫情防控债）发行公告（面向合格投资者）
2020.02.12
第四届董事会第二十九次会议决议公告
第一页
上一页
40
41
42
43
44
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
